ArticleThe Journal of clinical investigation2020

HDAC inhibitors elicit metabolic reprogramming by targeting super-enhancers in glioblastoma models.

Trang Thi Thu Nguyen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.